Abbott Laboratories (ABT) Depreciation & Amortization (CF) (2012 - 2015)

Abbott Laboratories has disclosed Depreciation & Amortization (CF) across 3 years of filings, most recently posting $11.0 million for Q4 2015.

• In Q4 2015, Depreciation & Amortization (CF) changed N/A year-over-year to $11.0 million; the TTM figure through Sep 2016 stood at $11.0 million (up 22.22% YoY), while the FY2017 annual figure was $2.0 million, changed 0.0% from the prior year.
• Depreciation & Amortization (CF) came in at $11.0 million for Q4 2015 at Abbott Laboratories, up from $9.0 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $89.0 million in Q4 2012 to a low of $2.0 million in Q2 2012.
• Average Depreciation & Amortization (CF) over 3 years is $17.1 million, with a median of $8.5 million recorded in 2012.
• The largest YoY upside for Depreciation & Amortization (CF) was 300.0% in 2013 against a maximum downside of 80.9% in 2013.
• Over 3 years, Depreciation & Amortization (CF) stood at $89.0 million in 2012, then tumbled by 80.9% to $17.0 million in 2013, then sank by 35.29% to $11.0 million in 2015.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $11.0 million in Q4 2015, $9.0 million in Q3 2015, and $17.0 million in Q4 2013.